TORONTO and AACHEN, Germany, Feb. 24, 2025 /PRNewswire/ - Apotex Inc. (“Apotex”), the largest Canadian-based pharmaceutical company, and Grünenthal, a global leader in pain management and related ...

AACHEN, Germany and TORONTO, Feb. 24, 2025 /PRNewswire/ -- Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based ...

AACHEN, Germany and TORONTO, Feb. 24, 2025 /PRNewswire/ -- Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical ...

Objective: To determine the efficacy and tolerability of low-dose tamsulosin 0.2 mg/day in Chinese patients with symptomatic benign prostatic hyperplasia (BPH). Conclusions: Low-dose tamsulosin 0. ...

Objective: The meta-analysis aimed to estimate the efficacy of prophylactic tamsulosin on postoperative urinary retention (POUR) in male patients. Methods: Papers were searched in the PubMed, Embase, ...